Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Chemical Communications (Cambridge, England)
|
September 14, 2020
The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer
Thomas Scattolin, Enrica Bortolamiol, Stefano Palazzolo, et al.
RSC Advances
|
October 30, 2025
Synthesis of azulenyl-substituted gold(i)-carbene complexes and investigation of their anticancer activity
Martin C Dietl, Christopher Hüßler, Matthias Scherr, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin
Stefano Palazzolo, Mohamad Hadla, Concetta Russo Spena, et al.
International Journal of Pharmaceutics
|
December 15, 2021
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor
Muhammad Adeel, Gloria Saorin, Giacomo Boccalon, et al.
Journal of Cellular Physiology
|
January 31, 2019
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects
Concetta Russo Spena, Lucia De Stefano, Giulio Poli, et al.
Journal of Medicinal Chemistry
|
January 7, 2015
Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model
Ilaria Paterni, Simone Bertini, Carlotta Granchi, et al.
Journal of Medicinal Chemistry
|
February 5, 2019
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 18, 2017
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy
Samer Bayda, Mohamad Hadla, Stefano Palazzolo, et al.
Cancer Letters
|
November 15, 2025
Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer
Gloria Saorin, Matteo Mauceri, Isabella Caligiuri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 11, 2018
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer
Concetta Russo Spena, Lucia De Stefano, Stefano Palazzolo, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Chemical Communications (Cambridge, England)
|
September 14, 2020
The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer
Thomas Scattolin, Enrica Bortolamiol, Stefano Palazzolo, et al.
RSC Advances
|
October 30, 2025
Synthesis of azulenyl-substituted gold(i)-carbene complexes and investigation of their anticancer activity
Martin C Dietl, Christopher Hüßler, Matthias Scherr, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin
Stefano Palazzolo, Mohamad Hadla, Concetta Russo Spena, et al.
International Journal of Pharmaceutics
|
December 15, 2021
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor
Muhammad Adeel, Gloria Saorin, Giacomo Boccalon, et al.
Journal of Cellular Physiology
|
January 31, 2019
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects
Concetta Russo Spena, Lucia De Stefano, Giulio Poli, et al.
Journal of Medicinal Chemistry
|
January 7, 2015
Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model
Ilaria Paterni, Simone Bertini, Carlotta Granchi, et al.
Journal of Medicinal Chemistry
|
February 5, 2019
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 18, 2017
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy
Samer Bayda, Mohamad Hadla, Stefano Palazzolo, et al.
Cancer Letters
|
November 15, 2025
Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer
Gloria Saorin, Matteo Mauceri, Isabella Caligiuri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 11, 2018
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer
Concetta Russo Spena, Lucia De Stefano, Stefano Palazzolo, et al.
Page
of 8